{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:06:54Z","timestamp":1773047214536,"version":"3.50.1"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","award":["not available"],"award-info":[{"award-number":["not available"]}],"id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0500_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To present the first Korean case of thyroid hormone metabolism defect (THMD) caused by compound heterozygous\n                      <jats:italic>SECISBP2<\/jats:italic>\n                      mutations and to expand our current understanding of its clinical spectrum.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0500_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 3-year-old girl presented with short stature, global developmental delay, bilateral semiptosis, and congenital sensorineural hearing loss. Thyroid function tests revealed decreased T3, elevated free T4, and normal TSH. Genetic analysis identified compound heterozygous nonsense variants in\n                      <jats:italic>SECISBP2<\/jats:italic>\n                      : a previously reported p.Arg120Ter and a novel p.Arg672Ter. Treatment with liothyronine normalized thyroid function, but developmental and speech delays persisted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0500_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This case broadens the mutational spectrum of\n                      <jats:italic>SECISBP2<\/jats:italic>\n                      -related THMD and demonstrates its multisystemic nature, including auditory and possible ocular involvement. Despite biochemical improvement, neurodevelopmental outcomes remained poor, emphasizing tissue-specific T3 deficiency and the limited efficacy of current therapy. Early recognition and molecular diagnosis are crucial for timely management and long-term follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0500","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:06:01Z","timestamp":1764317161000},"page":"291-296","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid hormone metabolism defect due to compound heterozygous\n                    <i>SECISBP2<\/i>\n                    mutations: first reported case in Korea"],"prefix":"10.1515","volume":"39","author":[{"given":"Jina","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pediatrics , School of Medicine, Soonchunhyang University Cheonan Hospital , Cheonan , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , School of Medicine, Jeju National University , Jeju , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-9600","authenticated-orcid":false,"given":"Hwal Rim","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , School of Medicine, Soonchunhyang University Cheonan Hospital , Cheonan , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"2026030908103969165_j_jpem-2025-0500_ref_001","doi-asserted-by":"crossref","unstructured":"Hamajima, T, Mushimoto, Y, Kobayashi, H, Saito, Y, Onigata, K. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur J Endocrinol 2012;166:757\u201364. https:\/\/doi.org\/10.1530\/eje-11-0812.","DOI":"10.1530\/EJE-11-0812"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_002","doi-asserted-by":"crossref","unstructured":"Lee, KW, Shin, Y, Lee, S, Lee, S. Inherited disorders of thyroid hormone metabolism defect caused by the dysregulation of selenoprotein expression. Front Endocrinol 2021;12:803024. https:\/\/doi.org\/10.3389\/fendo.2021.803024.","DOI":"10.3389\/fendo.2021.803024"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_003","doi-asserted-by":"crossref","unstructured":"Schoenmakers, E, Agostini, M, Mitchell, C, Schoenmakers, N, Papp, L, Rajanayagam, O, et al.. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J\u00a0Clin Investig 2010;120:4220\u201335. https:\/\/doi.org\/10.1172\/jci43653.","DOI":"10.1172\/JCI43653"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_004","doi-asserted-by":"crossref","unstructured":"Papp, LV, Wang, J, Kennedy, D, Boucher, D, Zhang, Y, Gladyshev, VN, et al.. Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res 2008;36:7192\u2013206. https:\/\/doi.org\/10.1093\/nar\/gkn829.","DOI":"10.1093\/nar\/gkn829"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_005","doi-asserted-by":"crossref","unstructured":"Simonovi\u0107, M, Puppala, AK. On elongation factor eEFSec, its role and mechanism during selenium incorporation into nascent selenoproteins. Biochim Biophys Acta Gen Subj 2018;1862:2463\u201372. https:\/\/doi.org\/10.1016\/j.bbagen.2018.03.018.","DOI":"10.1016\/j.bbagen.2018.03.018"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_006","doi-asserted-by":"crossref","unstructured":"Copeland, PR, Fletcher, JE, Carlson, BA, Hatfield, DL, Driscoll, DM. A novel RNA binding protein, SBP2, is required for the translation of Mammalian selenoprotein mRNAs. Embo J 2000;19:306\u201314. https:\/\/doi.org\/10.1093\/emboj\/19.2.306.","DOI":"10.1093\/emboj\/19.2.306"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_007","doi-asserted-by":"crossref","unstructured":"Di Cosmo, C, McLellan, N, Liao, XH, Khanna, KK, Weiss, RE, Papp, L, et al.. Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J\u00a0Clin Endocrinol Metab 2009;94:4003\u20139. https:\/\/doi.org\/10.1210\/jc.2009-0686.","DOI":"10.1210\/jc.2009-0686"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_008","doi-asserted-by":"crossref","unstructured":"Azevedo, MF, Barra, GB, Naves, LA, Ribeiro Velasco, LF, Godoy Garcia Castro, P, de Castro, LC, et al.. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J\u00a0Clin Endocrinol Metab 2010;95:4066\u201371. https:\/\/doi.org\/10.1210\/jc.2009-2611.","DOI":"10.1210\/jc.2009-2611"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_009","doi-asserted-by":"crossref","unstructured":"\u00c7atli, G, Fujisawa, H, Kirbiyik, \u00d6, Mimoto, MS, Gen\u00e7pinar, P, \u00d6zdemir, TR, et al.. A novel homozygous selenocysteine insertion sequence binding protein 2 (SECISBP2, SBP2) gene mutation in a Turkish boy. Thyroid 2018;28:1221\u20133. https:\/\/doi.org\/10.1089\/thy.2018.0015.","DOI":"10.1089\/thy.2018.0015"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_010","doi-asserted-by":"crossref","unstructured":"Almohammadi, L, Alsayel, L, Aljumaa, M, Alhuthil, R, Alsagheir, A. Case report: a homozygous selenocysteine insertion sequence-binding protein 2 (SECISBP2) gene mutation in a pediatric patient. Front Pediatr 2025;13:1637116. https:\/\/doi.org\/10.3389\/fped.2025.1637116.","DOI":"10.3389\/fped.2025.1637116"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_011","doi-asserted-by":"crossref","unstructured":"Dumitrescu, AM, Liao, XH, Abdullah, MS, Lado-Abeal, J, Majed, FA, Moeller, LC, et al.. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005;37:1247\u201352. https:\/\/doi.org\/10.1038\/ng1654.","DOI":"10.1038\/ng1654"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_012","doi-asserted-by":"crossref","unstructured":"Stoupa, A, Franca, MM, Abdulhadi-Atwan, M, Fujisawa, H, Korwutthikulrangsri, M, Marchand, I, et al.. Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency. Genet Med 2024;26:101280. https:\/\/doi.org\/10.1016\/j.gim.2024.101280.","DOI":"10.1016\/j.gim.2024.101280"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_013","doi-asserted-by":"crossref","unstructured":"Dumitrescu, AM, Refetoff, S. The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta 2013;1830:3987\u20134003. https:\/\/doi.org\/10.1016\/j.bbagen.2012.08.005.","DOI":"10.1016\/j.bbagen.2012.08.005"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_014","doi-asserted-by":"crossref","unstructured":"Wang, N, Tan, HY, Li, S, Wang, D, Xu, Y, Zhang, C, et al.. SBP2 deficiency in adipose tissue macrophages drives insulin resistance in obesity. Sci Adv 2019;5:eaav0198. https:\/\/doi.org\/10.1126\/sciadv.aav0198.","DOI":"10.1126\/sciadv.aav0198"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_015","doi-asserted-by":"crossref","unstructured":"Schoenmakers, E, Chatterjee, K. Human genetic disorders resulting in systemic selenoprotein deficiency. Int J Mol Sci 2021;22:12927. https:\/\/doi.org\/10.3390\/ijms222312927.","DOI":"10.3390\/ijms222312927"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_016","doi-asserted-by":"crossref","unstructured":"Paragliola, RM, Corsello, A, Concolino, P, Ianni, F, Papi, G, Pontecorvi, A, et al.. Iodothyronine deiodinases and reduced sensitivity to thyroid hormones. FBL 2020;25:201\u201328. https:\/\/doi.org\/10.2741\/4803.","DOI":"10.2741\/4803"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_017","doi-asserted-by":"crossref","unstructured":"Fu, J, Korwutthikulrangsri, M, G\u00f6n\u00e7, EN, Sillers, L, Liao, XH, Alika\u015fifo\u011flu, A, et al.. Clinical and molecular analysis in 2 families with novel compound heterozygous SBP2 (SECISBP2) mutations. J\u00a0Clin Endocrinol Metab 2020;105:e6\u201311. https:\/\/doi.org\/10.1210\/clinem\/dgz169.","DOI":"10.1210\/clinem\/dgz169"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_018","doi-asserted-by":"crossref","unstructured":"Seeher, S, Mahdi, Y, Schweizer, U. Post-transcriptional control of selenoprotein biosynthesis. Curr Protein Pept Sci 2012;13:337\u201346. https:\/\/doi.org\/10.2174\/138920312801619448.","DOI":"10.2174\/138920312801619448"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_019","doi-asserted-by":"crossref","unstructured":"Dumitrescu, AM, Refetoff, S. Inherited defects of thyroid hormone metabolism. Ann Endocrinol 2011;72:95\u20138. https:\/\/doi.org\/10.1016\/j.ando.2011.03.011.","DOI":"10.1016\/j.ando.2011.03.011"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_020","doi-asserted-by":"crossref","unstructured":"K\u00f6hrle, J, Jakob, F, Contempr\u00e9, B, Dumont, JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005;26:944\u201384. https:\/\/doi.org\/10.1210\/er.2001-0034.","DOI":"10.1210\/er.2001-0034"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_021","doi-asserted-by":"crossref","unstructured":"Labunskyy, VM, Hatfield, DL, Gladyshev, VN. Selenoproteins: molecular pathways and physiological roles. Physiol Rev 2014;94:739\u201377. https:\/\/doi.org\/10.1152\/physrev.00039.2013.","DOI":"10.1152\/physrev.00039.2013"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_022","doi-asserted-by":"crossref","unstructured":"Reeves, MA, Hoffmann, PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009;66:2457\u201378. https:\/\/doi.org\/10.1007\/s00018-009-0032-4.","DOI":"10.1007\/s00018-009-0032-4"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_023","doi-asserted-by":"crossref","unstructured":"Kasaikina, MV, Hatfield, DL, Gladyshev, VN. Understanding selenoprotein function and regulation through the use of rodent models. Biochim Biophys Acta 2012;1823:1633\u201342. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.02.018.","DOI":"10.1016\/j.bbamcr.2012.02.018"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_024","doi-asserted-by":"crossref","unstructured":"Schweizer, U, Fradejas-Villar, N. Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism. FASEB J 2016;30:3669\u201381. https:\/\/doi.org\/10.1096\/fj.201600424.","DOI":"10.1096\/fj.201600424"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_025","doi-asserted-by":"crossref","unstructured":"Ng, L, Hernandez, A, He, W, Ren, T, Srinivas, M, Ma, M, et al.. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 2009;150:1952\u201360. https:\/\/doi.org\/10.1210\/en.2008-1419.","DOI":"10.1210\/en.2008-1419"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_026","doi-asserted-by":"crossref","unstructured":"Schoenmakers, E, Chatterjee, K. Human disorders affecting the selenocysteine incorporation pathway cause systemic selenoprotein deficiency. Antioxid Redox Signal 2020;33:481\u201397. https:\/\/doi.org\/10.1089\/ars.2020.8097.","DOI":"10.1089\/ars.2020.8097"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_027","doi-asserted-by":"crossref","unstructured":"Higuchi, A, Takahashi, K, Hirashima, M, Kawakita, T, Tsubota, K. Selenoprotein P controls oxidative stress in cornea. PLoS One 2010;5:e9911. https:\/\/doi.org\/10.1371\/journal.pone.0009911.","DOI":"10.1371\/journal.pone.0009911"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_028","doi-asserted-by":"crossref","unstructured":"Al-Bassam, L, Shearman, GC, Brocchini, S, Alany, RG, Williams, GR. The potential of selenium-based therapies for ocular oxidative stress. Pharmaceutics 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16050631.","DOI":"10.3390\/pharmaceutics16050631"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_029","doi-asserted-by":"crossref","unstructured":"Schoenmakers, E, Marelli, F, J\u00f8rgensen, HF, Visser, WE, Moran, C, Groeneweg, S, et al.. Selenoprotein deficiency disorder predisposes to aortic aneurysm formation. Nat Commun 2023;14:7994. https:\/\/doi.org\/10.1038\/s41467-023-43851-6.","DOI":"10.1038\/s41467-023-43851-6"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_030","doi-asserted-by":"crossref","unstructured":"Alehagen, U, Aaseth, J, Schomburg, L, Larsson, A, Opstad, T, Alexander, J. Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality. Free Radic Biol Med 2024;222:403\u201313. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.027.","DOI":"10.1016\/j.freeradbiomed.2024.06.027"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_031","doi-asserted-by":"crossref","unstructured":"Kang, D, Lee, J, Wu, C, Guo, X, Lee, BJ, Chun, JS, et al.. The role of selenium metabolism and selenoproteins in cartilage homeostasis and arthropathies. Exp Mol Med 2020;52:1198\u2013208. https:\/\/doi.org\/10.1038\/s12276-020-0408-y.","DOI":"10.1038\/s12276-020-0408-y"},{"key":"2026030908103969165_j_jpem-2025-0500_ref_032","doi-asserted-by":"crossref","unstructured":"Persani, L, Rodien, P, Moran, C, Visser, WE, Groeneweg, S, Peeters, R, et al.. 2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action. Eur Thyroid J. 2024;13.","DOI":"10.1530\/ETJ-24-0125"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0500\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0500\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:10:57Z","timestamp":1773043857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0500\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,28]]},"published-print":{"date-parts":[[2026,3,26]]}},"alternative-id":["10.1515\/jpem-2025-0500"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0500","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}